C M Hogaboam Selected Research

C M Hogaboam Research Topics

Disease

10	Inflammation (Inflammations) 08/2008 - 03/2000
7	Respiratory Hypersensitivity 08/2008 - 01/2000
7	Asthma (Bronchial Asthma) 03/2006 - 01/2000
6	Sepsis (Septicemia) 03/2001 - 03/2000
5	Peritonitis 03/2001 - 03/2000
4	Colitis 07/2001 - 03/2000
3	Idiopathic Interstitial Pneumonias 11/2008 - 05/2004
3	Idiopathic Pulmonary Fibrosis 11/2008 - 05/2004
3	Airway Remodeling 05/2005 - 02/2001
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2008 - 05/2004
2	Communicable Diseases (Infectious Diseases) 11/2008 - 01/2000
2	Lung Diseases (Lung Disease) 05/2005 - 05/2001
2	Eosinophilia 05/2005 - 06/2000
2	Fibrosis (Cirrhosis) 11/2001 - 02/2000
2	Infections 07/2001 - 07/2001
2	Hyperplasia 04/2001 - 02/2000
2	Pathologic Processes 04/2000 - 01/2000
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2000 - 03/2000
1	Pulmonary Sarcoidosis 04/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Lung Injury 01/2018
1	Allergic Bronchopulmonary Aspergillosis 03/2006
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2005
1	Respiratory Syncytial Virus Infections 07/2001
1	Cestode Infections (Tapeworm Infection) 07/2001
1	Liver Diseases (Liver Disease) 10/2000
1	Hypersensitivity (Allergy) 06/2000
1	Neoplasms (Cancer) 04/2000
1	Crohn Disease (Crohn's Disease) 03/2000
1	Ulcerative Colitis 03/2000

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 04/2018 - 03/2000
9	ChemokinesIBA 05/2005 - 01/2000
5	CC ChemokinesIBA 06/2007 - 05/2000
5	Interleukin-13IBA 05/2004 - 03/2000
3	CollagenIBA 11/2001 - 01/2000
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2008 - 05/2005
2	LigandsIBA 11/2008 - 06/2007
2	Chemokine CCL22IBA 05/2005 - 05/2000
2	Immunoglobulin E (IgE)IBA 05/2005 - 08/2000
2	Interleukin-4 (Interleukin 4)IBA 05/2004 - 04/2001
2	Therapeutic UsesIBA 04/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 03/2001 - 01/2000
2	Interleukin-10 (Interleukin 10)IBA 03/2001 - 03/2000
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2001 - 01/2001
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	Interferon Type IIBA 04/2018
1	Toll-Like Receptor 3IBA 04/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Antifungal AgentsIBA 03/2006
1	CCR7 ReceptorsIBA 01/2006
1	Immunoglobulin G (IgG)IBA 05/2005
1	AntigensIBA 05/2005
1	Chemokine CCL17IBA 05/2005
1	Pattern Recognition ReceptorsIBA 05/2005
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2004
1	Interferon-gamma (Interferon, gamma)IBA 05/2004
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 05/2004
1	Interleukin-18 (Interleukin 18)IBA 11/2001
1	Chemokine ReceptorsIBA 11/2001
1	Chemokine CCL3IBA 11/2001
1	AllergensIBA 07/2001
1	Dextran SulfateIBA 07/2001
1	Drinking WaterIBA 07/2001
1	Sulfonic AcidsIBA 01/2001
1	Met- RANTESIBA 01/2001
1	Chemotactic FactorsIBA 01/2001
1	Messenger RNA (mRNA)IBA 01/2001
1	Chemokine CCL5IBA 01/2001
1	Stem Cell FactorIBA 10/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2000
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Monocyte Chemoattractant ProteinsIBA 04/2000
1	Endothelin Receptor AntagonistsIBA 03/2000
1	Endothelins (Endothelin)IBA 03/2000
1	Peroxidase (Myeloperoxidase)IBA 03/2000
1	Leukotriene B4IBA 03/2000
1	Ro 48-5695IBA 03/2000
1	2,4-dinitrofluorobenzene sulfonic acidIBA 03/2000
1	Endothelin-1 (Endothelin 1)IBA 03/2000
1	Methacholine Chloride (Methacholine)FDA Link 02/2000
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2000
1	Neutralizing AntibodiesIBA 01/2000

Therapy/Procedure

5	Therapeutics 03/2006 - 05/2000
5	Ligation 11/2000 - 03/2000
5	Punctures 11/2000 - 03/2000
1	Rectal Administration 03/2000